The Global HIV Vaccine Enterprise together with its African partners organized a meeting of 60 researchers, regulators, funders and advocates on 16-17 March 2015 in Kigali, Rwanda to propose a Pan-African HIV Vaccine Development Agenda to ensure that no country, population or clade is left behind in this effort. That meeting built on discussions at other meetings such as the USAID consultation held in Nairobi, Kenya in May 2014.
A commentary recently published by Amapola Manrique, Gabriella Scarlatti, William Snow (Global HIV Vaccine Enterprise), Sabin Nsanzimana (Rwanda Biomedical Center) and Pontiano Kaleebu (MRC-UVRI) outlines the group’s fourpillar strategy to support development of effective HIV vaccines for Africa. An overview of the key recommendations is depicted below.
The article can be accessed here: Toward a Pan-African HIV Vaccine Development Agenda